208 related articles for article (PubMed ID: 8952541)
1. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
2. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.
Koochekpour S; Jeffers M; Wang PH; Gong C; Taylor GA; Roessler LM; Stearman R; Vasselli JR; Stetler-Stevenson WG; Kaelin WG; Linehan WM; Klausner RD; Gnarra JR; Vande Woude GF
Mol Cell Biol; 1999 Sep; 19(9):5902-12. PubMed ID: 10454537
[TBL] [Abstract][Full Text] [Related]
3. Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.
de Paulsen N; Brychzy A; Fournier MC; Klausner RD; Gnarra JR; Pause A; Lee S
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1387-92. PubMed ID: 11171960
[TBL] [Abstract][Full Text] [Related]
4. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients.
Mohr VH; Vortmeyer AO; Zhuang Z; Libutti SK; Walther MM; Choyke PL; Zbar B; Linehan WM; Lubensky IA
Am J Pathol; 2000 Nov; 157(5):1615-21. PubMed ID: 11073821
[TBL] [Abstract][Full Text] [Related]
5. Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression.
Schraml P; Hergovich A; Hatz F; Amin MB; Lim SD; Krek W; Mihatsch MJ; Moch H
Am J Pathol; 2003 Sep; 163(3):1013-20. PubMed ID: 12937142
[TBL] [Abstract][Full Text] [Related]
6. A mutation at IVS1 + 5 of the von Hippel-Lindau gene resulting in intron retention in transcripts is not pathogenic in a patient with a tongue cancer?: case report.
Asakawa T; Esumi M; Endo S; Kida A; Ikeda M
BMC Med Genet; 2012 Mar; 13():23. PubMed ID: 22462637
[TBL] [Abstract][Full Text] [Related]
7. A Rare Case of Synchronous Fumarate Hydratase-Deficient Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma With Fumarate Hydratase and von Hippel-Lindau Gene Mutations: A Clinicopathologic and Molecular Study.
Wen H; Zheng L; Zhang M; Pan X; Wang D; Qian J; Zhang X; Zhou Q; Chen N
Int J Surg Pathol; 2024 Jun; 32(4):810-816. PubMed ID: 37715637
[TBL] [Abstract][Full Text] [Related]
8. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas.
Kikuchi Y; Kobayashi E; Nishizawa M; Hamazaki S; Okada S; Hino O
Jpn J Cancer Res; 1995 Oct; 86(10):905-9. PubMed ID: 7493907
[TBL] [Abstract][Full Text] [Related]
9. The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.
Peruzzi B; Athauda G; Bottaro DP
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14531-6. PubMed ID: 16983094
[TBL] [Abstract][Full Text] [Related]
10. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.
McRonald FE; Morris MR; Gentle D; Winchester L; Baban D; Ragoussis J; Clarke NW; Brown MD; Kishida T; Yao M; Latif F; Maher ER
Mol Cancer; 2009 Jun; 8():31. PubMed ID: 19493342
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC.
Li L; Bao H; Xu Y; Yang W; Zhang Z; Ma K; Zhang K; Zhou J; Gong Y; Ci W; Gong K
Mol Diagn Ther; 2023 Nov; 27(6):741-752. PubMed ID: 37587253
[TBL] [Abstract][Full Text] [Related]
12. Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution.
Fisher R; Horswell S; Rowan A; Salm MP; de Bruin EC; Gulati S; McGranahan N; Stares M; Gerlinger M; Varela I; Crockford A; Favero F; Quidville V; André F; Navas C; Grönroos E; Nicol D; Hazell S; Hrouda D; O'Brien T; Matthews N; Phillimore B; Begum S; Rabinowitz A; Biggs J; Bates PA; McDonald NQ; Stamp G; Spencer-Dene B; Hsieh JJ; Xu J; Pickering L; Gore M; Larkin J; Swanton C
Genome Biol; 2014 Aug; 15(8):433. PubMed ID: 25159823
[TBL] [Abstract][Full Text] [Related]
13. Does the VHL polymorphisms rs779805 and rs1642742 affect renal cell carcinoma susceptibility, prognosis and survival in Central European population?
Chrabańska M; Szweda-Gandor N; Drozdzowska B
Medicine (Baltimore); 2023 Dec; 102(50):e36540. PubMed ID: 38115281
[TBL] [Abstract][Full Text] [Related]
14. Exosomes from Von Hippel-Lindau-Null Cancer Cells Promote Metastasis in Renal Cell Carcinoma.
Flora K; Ishihara M; Zhang Z; Bowen ES; Wu A; Ayoub T; Huang J; Cano-Ruiz C; Jackson M; Reghu K; Ayoub Y; Zhu Y; Tseng HR; Zhou ZH; Hu J; Wu L
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139136
[TBL] [Abstract][Full Text] [Related]
15. Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours.
Fei SS; Mitchell AD; Heskett MB; Vocke CD; Ricketts CJ; Peto M; Wang NJ; Sönmez K; Linehan WM; Spellman PT
Nat Commun; 2016 May; 7():11588. PubMed ID: 27174753
[TBL] [Abstract][Full Text] [Related]
16. Repurposing propranolol as an antitumor agent in von Hippel-Lindau disease.
Shepard MJ; Bugarini A; Edwards NA; Lu J; Zhang Q; Wu T; Zhuang Z; Chittiboina P
J Neurosurg; 2018 Oct; 131(4):1106-1114. PubMed ID: 30497198
[TBL] [Abstract][Full Text] [Related]
17. VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.
Lee H; Zhuang L; Gan B
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618953
[TBL] [Abstract][Full Text] [Related]
18. 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.
Finkelstein SD; Hasegawa T; Colby T; Yousem SA
Am J Pathol; 1999 Aug; 155(2):633-40. PubMed ID: 10433956
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and molecular features of renal cell carcinomas with haemangioblastoma-like features distinct from clear cell renal cell carcinoma.
Kojima F; Matsuzaki I; Musangile FY; Kinoshita Y; Otani T; Abe K; Asai A; Kohjimoto Y; Kondo T; Hara I; Murata SI
Histopathology; 2024 Feb; 84(3):539-549. PubMed ID: 37988260
[TBL] [Abstract][Full Text] [Related]
20. When rare diseases crisscross within the same patient: von Hippel-Lindau and type 1 gastric neuroendocrine tumor.
Alexandraki KI; Spyroglou A; Xekouki P; Bramis KI; Kyriakopoulos G; Barkas K; Papanikolaou IS; Mastorakos G; Konstadoulakis M
Hormones (Athens); 2024 Apr; ():. PubMed ID: 38619811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
